FR2226171A1 - - Google Patents

Info

Publication number
FR2226171A1
FR2226171A1 FR7411445A FR7411445A FR2226171A1 FR 2226171 A1 FR2226171 A1 FR 2226171A1 FR 7411445 A FR7411445 A FR 7411445A FR 7411445 A FR7411445 A FR 7411445A FR 2226171 A1 FR2226171 A1 FR 2226171A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7411445A
Other versions
FR2226171B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2319279A external-priority patent/DE2319279A1/de
Priority claimed from DE2363138A external-priority patent/DE2363138A1/de
Application filed by Bayer AG filed Critical Bayer AG
Publication of FR2226171A1 publication Critical patent/FR2226171A1/fr
Application granted granted Critical
Publication of FR2226171B1 publication Critical patent/FR2226171B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/24—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7411445A 1973-04-17 1974-03-29 Expired FR2226171B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2319279A DE2319279A1 (de) 1973-04-17 1973-04-17 Pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2363138A DE2363138A1 (de) 1973-12-19 1973-12-19 Pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
FR2226171A1 true FR2226171A1 (fr) 1974-11-15
FR2226171B1 FR2226171B1 (fr) 1978-07-28

Family

ID=25764995

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7411445A Expired FR2226171B1 (fr) 1973-04-17 1974-03-29

Country Status (21)

Country Link
US (1) US3952008A (fr)
JP (1) JPS59512B2 (fr)
AR (2) AR207445A1 (fr)
BG (2) BG22820A3 (fr)
CA (1) CA1048513A (fr)
CH (2) CH603593A5 (fr)
DD (1) DD113230A5 (fr)
DK (1) DK136155C (fr)
ES (2) ES425374A1 (fr)
FR (1) FR2226171B1 (fr)
GB (1) GB1424492A (fr)
HK (1) HK55876A (fr)
HU (1) HU168591B (fr)
IE (1) IE39213B1 (fr)
IL (1) IL44627A (fr)
LU (1) LU69871A1 (fr)
NL (1) NL7405116A (fr)
NO (1) NO139439C (fr)
PL (1) PL96880B1 (fr)
RO (2) RO63750A (fr)
SE (1) SE408552B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2313928A1 (fr) * 1975-06-13 1977-01-07 Bayer Ag Nouveaux derives pyrazoliques substitues en position 1, leur procede de preparation et medicament les contenant

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056533A (en) * 1973-04-17 1977-11-01 Bayer Aktiengesellschaft Pyrazol-5-ones
US4000294A (en) * 1973-04-17 1976-12-28 Bayer Aktiengesellschaft Pyrazol-5-ones
DE2319278C2 (de) * 1973-04-17 1986-02-20 Bayer Ag, 5090 Leverkusen Pharmazeutisches Mittel
USRE30420E (en) * 1973-04-17 1980-10-21 Bayer Aktiengesellschaft Pyrazol-5-ones
DE2427272C3 (de) * 1974-06-06 1981-10-01 Bayer Ag, 5090 Leverkusen 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum
JPS5585571A (en) * 1978-12-22 1980-06-27 Nippon Synthetic Chem Ind Co Ltd:The Preparation of 1,3-disubstituted-5-pyrazolone
JPH0730031B2 (ja) * 1986-04-02 1995-04-05 日産化学工業株式会社 ２―ピラゾリン―５―オン類の製造法
WO2006094201A2 (fr) * 2005-03-02 2006-09-08 La Jolla Pharmaceutical Company Inhibiteurs de l'amine oxydase sensible aux semicarbazides (ssao) et adhesion induite par vap-1 utilisee pour le traitement de maladies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2376380A (en) * 1945-05-22 Preparation of amino pyrazolones
GB636988A (en) * 1947-12-24 1950-05-10 Gevaert Photo Producten Naamlo Improvements in and relating to the production of colour photographic images
US2511231A (en) * 1949-03-26 1950-06-13 Eastman Kodak Co 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography
US2600788A (en) * 1949-06-07 1952-06-17 Eastman Kodak Co Halogen-substituted pyrazolone couplers for color photography
US2672417A (en) * 1949-12-31 1954-03-16 Gevaert Photo Prod Nv Production of color photographic images
NL279140A (fr) * 1961-05-31

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2313928A1 (fr) * 1975-06-13 1977-01-07 Bayer Ag Nouveaux derives pyrazoliques substitues en position 1, leur procede de preparation et medicament les contenant

Also Published As

Publication number Publication date
AR207445A1 (es) 1976-10-08
HK55876A (en) 1976-09-17
IE39213B1 (en) 1978-08-30
RO69408A (fr) 1980-06-15
US3952008A (en) 1976-04-20
LU69871A1 (fr) 1974-11-21
FR2226171B1 (fr) 1978-07-28
CH603593A5 (fr) 1978-08-31
IL44627A (en) 1978-07-31
AU6817574A (en) 1975-10-23
DD113230A5 (fr) 1975-05-20
NO139439B (no) 1978-12-04
CA1048513A (fr) 1979-02-13
HU168591B (fr) 1976-06-28
NL7405116A (fr) 1974-10-21
BG22394A3 (bg) 1977-02-20
JPS5012082A (fr) 1975-02-07
NO741364L (no) 1974-10-18
DK136155B (da) 1977-08-22
CH605799A5 (fr) 1978-10-13
IL44627A0 (en) 1974-06-30
RO63750A (fr) 1980-06-15
ES425374A1 (es) 1976-09-16
NO139439C (no) 1979-03-14
PL96880B1 (pl) 1978-01-31
DK136155C (da) 1978-01-30
ES447081A1 (es) 1977-06-16
BG22820A3 (bg) 1977-04-20
AR207242A1 (es) 1976-09-22
JPS59512B2 (ja) 1984-01-07
GB1424492A (en) 1976-02-11
SE408552B (sv) 1979-06-18
IE39213L (en) 1974-10-17

Similar Documents

Publication Publication Date Title
AU476761B2 (fr)
FR2226172B1 (fr)
AU476714B2 (fr)
FR2226171B1 (fr)
AR201229Q (fr)
AU476696B2 (fr)
AU477823B2 (fr)
AU476873B1 (fr)
AU477824B2 (fr)
BG21472A1 (fr)
AU479504A (fr)
CH566761A5 (fr)
CH566694A5 (fr)
CH565624A5 (fr)
CH564481A5 (fr)
CH563485A5 (fr)
CH559474A4 (fr)
BG23476A1 (fr)
AU479458A (fr)
BG20465A1 (fr)
BG19377A1 (fr)
BG18480A1 (fr)
AU479562A (fr)
AU479539A (fr)
AU479522A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse